BIO-key International Inc...

NASDAQ: BKYI · Real-Time Price · USD
0.74
-0.01 (-0.67%)
At close: Aug 15, 2025, 10:00 AM

BIO-key International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.91M 6.36M 6.93M 6.39M 6.06M 6.85M 7.75M 8.59M 8.14M 8.16M 7.02M 6.2M 6.12M 5.17M 5.11M 5.24M 4.89M 4.2M
Cost of Revenue
1.47M 1.27M 1.29M 5.45M 5.41M 5.75M 6.27M 2.44M 2.4M 2.52M 2.04M 1.83M 1.73M 1.24M 1.67M 1.61M 1.53M 1.44M
Gross Profit
5.44M 5.09M 5.64M 944.77K 666.85K 1.11M 1.49M 6.16M 5.74M 5.64M 4.98M 4.37M 4.39M 3.92M 3.44M 3.63M 3.36M 2.77M
Operating Income
-3.57M -4.14M -4.01M -9.27M -10.65M -10.18M -9.98M -8.22M -8.65M -9.19M -9.88M -7.12M -5.71M -5.11M -4.82M -4.24M -4.36M -4.62M
Interest Income
2.15K 106.00 108.00 5.64K 11.56K 11.53K 11.53K 5.96K 52.00 106.00 233.00 515.00 836.00 1.59K 4.08K 7.52K 8.29K 33.26K
Pretax Income
-4.05M -4.55M -4.32M -9.37M -10.46M -10.08M -10.09M -8.75M -9.32M -9.76M -10.23M -7.15M -5.77M -5.21M -4.95M -4.35M -6.65M -7.06M
Net Income
-4.21M -4.71M -4.48M -9.09M -10.19M -9.94M -10.06M -9.32M -9.88M -10.18M -10.56M -7.15M -5.77M -5.21M -4.95M -4.35M -6.65M -7.06M
Selling & General & Admin
6.47M 6.73M 7.14M 7.77M 7.76M 7.76M 7.86M 8.74M 9.66M 9.73M 9.64M 8.07M 6.94M 6.31M 5.91M 5.92M 6.05M 5.89M
Research & Development
2.54M 2.5M 2.51M 2.44M 2.35M 2.31M 2.39M 2.64M 2.91M 3.14M 3.25M 3.23M 3.01M 2.72M 2.36M 1.95M 1.67M 1.5M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 262.82K 302.82K 452.82K 452.82K 220K 210K 60K 60K 30K n/a -340.82K
Operating Expenses
9.01M 9.23M 9.65M 10.21M 10.1M 10.07M 10.25M 11.65M 12.88M 13.32M 13.35M 11.52M 10.16M 9.09M 8.32M 7.91M 7.72M 7.05M
Interest Expense
467.04K 394.31K 299.75K 231.71K 118.81K 162.71K 218.27K 185.72K 142.13K 86.87K 29.95K 3.61K 1.54K n/a 18K 37.63K 2.24M 2.81M
Selling & Marketing Expenses
n/a n/a n/a 497.27K 497.27K 497.27K 497.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.48M 10.5M 10.94M 15.66M 16.72M 17.03M 17.73M 15.29M 15.28M 15.84M 15.39M 13.34M 11.89M 10.33M 10M 9.52M 9.25M 8.48M
Income Tax Expense
-23K -23K -23K -276.82K -277.01K -134.01K -35.02K 563.29K 565.54K 424K 324.88K 3.69K 1.63K 168.00 -76.22K -76.52K -99.65K -99.65K
Shares Outstanding (Basic)
5.82M 4.7M 3.03M 1.89M 1.66M 1.62M 1.09M 570.75K 556.76K 480.83K 457.2K 452.71K 449.89K 438.06K 433.2K 432.82K 432.01K 431.87K
Shares Outstanding (Diluted)
5.82M 4.7M 3.03M 1.89M 1.66M 1.62M 1.09M 570.75K 556.76K 480.83K 457.2K 452.71K 449.89K 438.06K 433.2K 432.82K 432.01K 431.87K
EPS (Basic)
-1.27 -2.07 -2.23 -7.38 -10.21 -11.77 -12.75 -18.96 -21.05 -22.31 -23.29 -16.09 -13.15 -12.02 -11.43 -10.08 -16.98 -25.14
EPS (Diluted)
-1.27 -2.07 -2.23 -7.38 -10.21 -11.77 -12.75 -18.96 -21.05 -22.31 -23.29 -16.09 -13.15 -12.02 -11.43 -10.08 -16.98 -25.14
EBITDA
-3.37M -3.84M -3.61M -8.64M -8.66M -9.39M -10.64M -9.32M -11.1M -10.46M -9.66M -6.69M -5.36M -4.83M -4.72M -4.04M -4.15M -3.94M
EBIT
-3.58M -4.16M -4.02M -9.07M -10.35M -11.12M -12.24M -12.65M -13.26M -12.53M -11.9M -7.13M -5.75M -5.21M -5.05M -4.44M -4.5M -4.35M
Depreciation & Amortization
373.59K 473.74K 477.53K 489.45K 490.56K 531.35K 590.14K 610.57K 672.07K 589.59K 546.01K 461.03K 421.69K 487.27K 506.49K 734.54K 635.09K 536.08K